1. Context
2. Objectives
3. Methods
4. Results
| Author | Place | Year | Total | Male | Female | Age, Mean ± SD |
|---|---|---|---|---|---|---|
| Pugh Smith and Nriagu (5) | USA | 2011 | 361 | 177 | 184 | 5.9 ± 4.37 |
| Joseph et al. (20) | USA | 2005 | 4634 | 234 | 2294 | 1.2 ± 0.5 |
| Wang et al. (21) | China | 2017 | 930 | 469 | 461 | 5.74 ± 0.77 |
| Wu et al. (22) | Taiwan | 2018 | 5866 | 3053 | 2813 | 7.5 ± 1.5 |
| Ghaffari et al. (15) | Iran | 2014 | 284 | 143 | 141 | 7.8 ± 1.2 |
| Mohamed et al. (23) | Egypt | 2018 | 60 | 32 | 28 | 44.5 ± 6.54 |
| Vural et al. (24) | Turkey | 2000 | 84 | 37 | 47 | 36.2 ± 11.7 |
| Variables | Article (n) | % | 95% CI | I2 | P-Value |
|---|---|---|---|---|---|
| Prevalence of asthma | 4 | 12 | 11 - 13 | 90.9 | 0.000 |
| Blood lead level | 4 | 2 | 2 - 3 | 98.6 | 0.000 |
| Asthma and lead | 2 | 3 | 3 - 4 | 98.7 | 0.000 |
| Blood lead level grade, μg/dL | |||||
| < 5 | 2 | 8 | 7 - 9 | 98.5 | 0.000 |
| 5 - 10 | 2 | 10 | 8 - -11 | 98.1 | 0.000 |
| > 10 | 2 | 9 | 8 - -11 | 97.2 | 0.000 |
| Age group, y | |||||
| 2 - 5 | 2 | 15 | 15 - 15 | 98.3 | 0.000 |
| 6 - 11 | 2 | 3 | 2 - 3 | 98.5 | 0.000 |
| 12 - 15 | 2 | 1 | 1 - 1 | 98.9 | 0.000 |
| Ethnicity | |||||
| American-Spanish | 3 | 30 | 26 - 34 | 97.4 | 0.000 |
| Asia-Caucasian | 3 | 33 | 29 - 37 | 97.4 | 0.000 |
| Variables and Subgroups | Article (n) | % | 95% CI | I2 | P-Value |
|---|---|---|---|---|---|
| Mean by μg/dL | |||||
| Mean zinc in the case group | 3 | 70.44 | 57.63 - 83.24 | 80.9 | 0.005 |
| Mean zinc in the control group | 3 | 74.1 | 63.86 - 84.34 | 92.6 | 0.000 |
| FEV | |||||
| Mean in the case group | 2 | 81.8 | 74.71 - 88.89 | 74.8 | 0.047 |
| Mean in the control group | 1 | 93.4 | 83.8 - 100 | 100 | 0.000 |
A, Meta-regression for investigating the relationship between asthma and blood lead level based on publication year indicating an increasing occurrence from 2005 to 2018. B, Meta-regression for investigating the relationship between asthma and blood lead level based on the sample size revealing a higher occurrence of asthma in studies with larger sample sizes.
A, Meta-regression for investigating the relationship between asthma and zinc based on the publication year indicating an increasing occurrence from 2005 to 2018. B, Meta-regression for investigating the relationship between asthma and zinc based on the sample size revealing a higher occurrence of asthma in studies with larger sample sizes
Forest plot of the mean age along with the 95% confidence interval. A, Mean Age of patients in the studies assessing the relationship between asthma and BLL was 2.93 years (95% CI: 2.14 - 3.72, I2 = 91.4%, P < 0.001). B, Mean age of patients in the studies assessing the relationship between asthma and zinc was 9.27 years (95% CI: 6.97 - 11.57, I2 = 94.4%, P < 0.001). The Middle point in each line represents the mean age in each study. The diamond shape indicates the confidence interval of the overall mean age.



